CARBIDOPA, LEVODOPA AND ENTACAPONE 75 mg/1

Carbidopa, Levodopa, and Entacapone 75 mg/1 tablets are a combination medication used to manage symptoms of Parkinson's disease. This oral treatment helps regulate dopamine levels in the brain, supporting motor function and mobility.

Carbidopa, Levodopa, and Entacapone 75 mg/1 tablets are primarily used to treat Parkinson's disease. The medication works by increasing dopamine levels in the brain, which helps alleviate symptoms such as tremors, stiffness, and difficulty moving. This combination therapy is often prescribed to improve motor function and quality of life for individuals with Parkinson's disease.

Common effects of Carbidopa, Levodopa, and Entacapone 75 mg/1 tablets may include nausea, dizziness, and headache. Some users may also experience insomnia or changes in appetite. These effects vary among individuals and typically subside as the body adjusts to the medication.

Carbidopa, Levodopa, and Entacapone 75 mg/1 tablets should be handled with care. Store the medication in a cool, dry place away from direct sunlight. Always follow the prescribed dosage and consult a healthcare provider before starting or stopping the medication. Avoid alcohol and other medications that may interact with this treatment.

Carbidopa, Levodopa, and Entacapone 75 mg/1 tablets may interact with certain medications, including antidepressants, antipsychotics, and blood pressure drugs. Alcohol and other substances that affect the central nervous system should be avoided. Always inform your healthcare provider about all medications and supplements you are taking.